Case C-261/21: Judgment of the Court (Ninth Chamber) of 7 July 2022 (request for a preliminary ruling from the Consiglio di Stato — Italy) — F. Hoffmann-La Roche Ltd, Novartis AG, Novartis Farma SpA, Roche SpA v Autorità Garante della Concorrenza e del Mercato (Reference for a preliminary ruling — Second subparagraph of Article 19(1) TEU — Obligation on Member States to provide remedies sufficient to ensure effective legal protection in the fields covered by EU law — Article 267 TFEU — Obligation on the referring court to give full effect to the interpretation of EU law provided by the Court of Justice — Charter of Fundamental Rights of the European Union — Article 47 — Access to an independent and impartial tribunal previously established by law — Judgment of a national court of last instance after a preliminary ruling by the Court — Alleged non-conformity of that judgment with the interpretation of EU law provided by the Court — National legislation preventing the bringing of an action for revision of that judgment)
Date: 2022-07-07
Institutions: Court of Justice
Subjects: EU law - national law, access to the courts, action brought before an administrative court, administrative court, appeal, higher court, interpretation of the law, right to justice








C_2022318EN.01001601.xml










22.8.2022   


EN


Official Journal of the European Union


C 318/16






Judgment of the Court (Ninth Chamber) of 7 July 2022 (request for a preliminary ruling from the Consiglio di Stato — Italy) — F. Hoffmann-La Roche Ltd, Novartis AG, Novartis Farma SpA, Roche SpA v Autorità Garante della Concorrenza e del Mercato
(Case C-261/21) (1)

(Reference for a preliminary ruling - Second subparagraph of Article 19(1) TEU - Obligation on Member States to provide remedies sufficient to ensure effective legal protection in the fields covered by EU law - Article 267 TFEU - Obligation on the referring court to give full effect to the interpretation of EU law provided by the Court of Justice - Charter of Fundamental Rights of the European Union - Article 47 - Access to an independent and impartial tribunal previously established by law - Judgment of a national court of last instance after a preliminary ruling by the Court - Alleged non-conformity of that judgment with the interpretation of EU law provided by the Court - National legislation preventing the bringing of an action for revision of that judgment)
(2022/C 318/21)
Language of the case: Italian

Referring court

Consiglio di Stato

Parties to the main proceedings


Applicants: F. Hoffmann-La Roche Ltd, Novartis AG, Novartis Farma SpA, Roche SpA

Defendant: Autorità Garante della Concorrenza e del Mercato

Interveners: Società Oftalmologica Italiana (SOI) — Associazione Medici Oculisti Italiani (AMOI), Regione Emilia-Romagna, Regione Lombardia, Altroconsumo, Novartis Farma SpA, Roche SpA, Novartis AG, F. Hoffmann-La Roche Ltd, Associazione Italiana delle Unità Dedicate Autonome Private di Day Surgery e dei Centri di Chirurgia Ambulatoriale (Aiudapds), Coordinamento delle associazioni per la tutela dell’ambiente e dei diritti degli utenti e consumatori (Codacons), Ministero della Salute — Agenzia Italiana del Farmaco

Operative part of the judgment

Article 4(3) and Article 19(1) TEU, and Article 267 TFEU, read in the light of Article 47 of the Charter of Fundamental Rights of the European Union, must be interpreted as not precluding provisions of procedural law of a Member State which, while observing the principle of equivalence, have the effect that, where the supreme court of the administrative system of that Member State gives a decision settling a dispute in which it had made a request to the Court of Justice for a preliminary ruling under Article 267 TFEU, the parties to that dispute may not seek a revision of that decision of the national court based on the contention that the latter disregarded the interpretation of EU law provided by the Court of Justice in response to that request.


(1)  OJ C 263, 5.7.2021.